Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
Drug Launch
Board Meeting
|
Mid-range Performer
2037.4000
22.60
(
1.12
%)
NSE
May 09, 2025
15:31 PM
36.44% Gain from 52W Low
Volume:
558.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
13 Feb 2025
Drug Launch
Board Meeting
2037.40
1.12%
LUPIN LTD
Buy:
Lupin Ltd.
by
Prabhudas Lilladhar
Target: 2420 | Upside : 18.8%
Recommendation
Target
Prabhudas Lilladhar
Lupin Ltd. is trading
above its 50 day SMA
of 2010.2
More from Lupin Ltd.
Recommended
Five Interesting Stocks Today - May 09, 2025
The Baseline |
09 May 2025
Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore
Trendlyne Marketwatch |
09 May 2025
Lupin expects normalization by September quarter
|
17 Apr 2020